Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
CC transcript

Revance Therapeutics, Inc. (RVNC) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/15/2023 4 Schilke Tobin (CFO) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Granted 22,620 shares @ $0
Paid exercise price by delivering 11,215 shares @ $18.91, valued at $212.1k
08/15/2023 4 Moxie Dwight (SVP, GC & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Granted 19,346 shares @ $0
Paid exercise price by delivering 9,592 shares @ $18.91, valued at $181.4k
08/15/2023 4 Sjuts Dustin S (President) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Granted 22,620 shares @ $0
Paid exercise price by delivering 8,901 shares @ $18.91, valued at $168.3k
08/15/2023 4 Foley Mark J (CEO) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Granted 122,143 shares @ $0
Paid exercise price by delivering 48,064 shares @ $18.91, valued at $908.9k
08/04/2023 4 Foley Mark J (CEO) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Sold 26,279 shares @ $22.5713, valued at $593.2k
07/05/2023 4 Schilke Tobin (CFO) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Granted 769 shares @ $15.606, valued at $12k
Sold 1,701 shares @ $25.04, valued at $42.6k
07/05/2023 4 Sjuts Dustin S (President) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Granted 1,000 shares @ $15.606, valued at $15.6k
07/05/2023 4 Foley Mark J (CEO) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Granted 1,000 shares @ $15.606, valued at $15.6k
Sold 26,279 shares @ $24.9375, valued at $655.3k
06/05/2023 4 Schilke Tobin (CFO) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Sold 2,701 shares @ $30.57, valued at $82.6k
Sold 500 shares @ $31, valued at $15.5k
05/16/2023 4 Moxie Dwight (SVP, GC & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Granted 42,349 shares @ $0
Sold 21,401 shares @ $34.5469, valued at $739.3k
05/16/2023 4 Schilke Tobin (CFO) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Granted 42,349 shares @ $0
Sold 21,401 shares @ $34.5469, valued at $739.3k
05/16/2023 4 Foley Mark J (CEO) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Granted 175,649 shares @ $0
Sold 70,447 shares @ $34.5469, valued at $2.4M
05/16/2023 4 Sjuts Dustin S (President) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Granted 52,395 shares @ $0
Sold 21,015 shares @ $34.5469, valued at $726k
05/05/2023 4 Gangolli Julian S (Director) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Granted 3,534 shares @ $0
Granted 5,915 options to buy @ $33.61, valued at $198.8k
05/05/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/05/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/05/2023 4 Kolaja Carey OConnor (Director) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Granted 3,534 shares @ $0
Granted 5,915 options to buy @ $33.61, valued at $198.8k
05/05/2023 4 Russell Angus C. (Director) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Granted 3,534 shares @ $0
Granted 5,915 options to buy @ $33.61, valued at $198.8k
05/05/2023 4 Coric Vlad (Director) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Granted 589 shares @ $0
Granted 986 options to buy @ $33.61, valued at $33.1k
05/05/2023 4 Beraud Jill (Director) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Granted 3,534 shares @ $0
Granted 5,915 options to buy @ $33.61, valued at $198.8k
04/04/2023 4 Schilke Tobin (CFO) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Sold 3,201 shares @ $32.15, valued at $102.9k
03/17/2023 4 Foley Mark J (CEO) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Paid exercise price by delivering 5,341 shares @ $30.65, valued at $163.7k
03/17/2023 4 Schilke Tobin (CFO) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Paid exercise price by delivering 3,739 shares @ $30.65, valued at $114.6k
03/17/2023 4 Moxie Dwight (SVP, GC & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Paid exercise price by delivering 7,330 shares @ $30.65, valued at $224.7k
03/17/2023 4 Sjuts Dustin S (President) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Paid exercise price by delivering 2,967 shares @ $30.65, valued at $90.9k
03/09/2023 4 Moxie Dwight (SVP, GC & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Granted 42,349 shares @ $0
Sold 18,496 shares @ $31.5863, valued at $584.2k
03/09/2023 4 Schilke Tobin (CFO) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Granted 42,349 shares @ $0
Sold 18,517 shares @ $31.5863, valued at $584.9k
03/09/2023 4 Sjuts Dustin S (President) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Granted 52,396 shares @ $0
Sold 21,508 shares @ $31.5863, valued at $679.4k
03/09/2023 4 Foley Mark J (CEO) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Granted 175,649 shares @ $0
Sold 70,390 shares @ $31.5863, valued at $2.2M
03/02/2023 4 Schilke Tobin (CFO) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Sold 3,201 shares @ $33.5, valued at $107.2k
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/23/2023 4 Schilke Tobin (CFO) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Sold 1,000 shares @ $31, valued at $31k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy